Aimz Investment Advisors, LLC Myriad Genetics Inc Transaction History

Aimz Investment Advisors, LLC

$283 Million
Q1 2025

A detailed history of Aimz Investment Advisors, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 39,185 shares of MYGN stock, worth $192,790. This represents 0.12% of its overall portfolio holdings.

Number of Shares

39,185

Previous 39,185 -0.0%

Holding current value

$192,790

Previous $537,000 35.38%

% of portfolio

0.12%

Previous 0.19%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$13.17 - $27.03 $2,634 - $5,406	-200 Reduced 0.51%	39,185 $537,000
Q3 2024 Nov 13, 2024	SELL	$23.97 - $28.6 $4,794 - $5,720	-200 Reduced 0.51%	39,385 $1.08 Million
Q1 2024 May 10, 2024	SELL	$17.59 - $23.59 $21,108 - $28,308	-1,200 Reduced 2.94%	39,585 $843,000
Q4 2023 Jan 26, 2024	SELL	$13.91 - $21.32 $2,782 - $4,264	-200 Reduced 0.49%	40,785 $780,000
Q3 2023 Nov 13, 2023	SELL	$15.99 - $23.22 $11,193 - $16,254	-700 Reduced 1.68%	40,985 $657,000
Q4 2022 Feb 10, 2023	SELL	$14.51 - $20.99 $5,804 - $8,396	-400 Reduced 0.95%	41,685 $605,000
Q2 2022 Aug 02, 2022	SELL	$16.45 - $25.88 $9,870 - $15,528	-600 Reduced 1.41%	42,085 $765,000
Q1 2022 May 06, 2022	SELL	$22.67 - $28.01 $34,005 - $42,015	-1,500 Reduced 3.39%	42,685 $1.08 Million
Q4 2021 Feb 09, 2022	BUY	$24.13 - $32.63 $36,195 - $48,945	1,500 Added 3.51%	44,185 $1.22 Million
Q2 2020 Aug 07, 2020	SELL	$10.69 - $16.49 $2,138 - $3,297	-200 Reduced 0.47%	42,685 $484,000
Q4 2019 Feb 13, 2020	SELL	$20.93 - $35.1 $12,558 - $21,060	-600 Reduced 1.38%	42,885 $1.17 Million
Q3 2018 Nov 13, 2018	SELL	$37.57 - $50.34 $18,785 - $25,170	-500 Reduced 1.14%	43,485 $2 Million
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $5,550 - $8,034	200 Added 0.46%	43,985 $1.64 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $2,845 - $3,714	-100 Reduced 0.23%	43,785 $1.5 Million
Q2 2017 Aug 15, 2017	BUY	N/A	43,885	43,885 $1.13 Million

Others Institutions Holding MYGN

# of Institutions

240

Shares Held

95.3M

Call Options Held

95.4K

Put Options Held

18.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $397M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.

Account

Aimz Investment Advisors, LLC Myriad Genetics Inc Transaction History